Accretion Pharmaceuticals

Accretion Pharmaceuticals

NSE SME

₹121,200 / 1200 Shares

Offer Date:May 14, 2025 - May 16, 2025

IPO Live Subscription Details (times)

Date:16-May-2025 17:58:00 hrs
QIBs:12.14
NII:4.40
Retail:10.54x
Total:7.73 times

IPO Details

Accretion Pharmaceuticals IPO is priced between ₹96-101 per equity share, with a face value of ₹10 per share. The company's equity shares will be listed on the NSE SME, and Kfin Technologies Limited is managing the issue as the registrar.

The IPO bidding period opened on 14 May, 2025, and closed on 16 May, 2025. The allotment results will be announced on 19 May, 2025, with a tentative listing date set for 21 May, 2025.

The total issue comprises 29,46,000 shares, amounting to ₹29.75 Cr.

Accretion Pharmaceuticals IPO Highlights

IPO DateListing DateFace ValuePrice BandLot SizeFresh IssueOffer for SaleListing At
May 14, 2025 - May 16, 202521 May, 2025₹10 Per Equity Share₹96-101 per equity share- Shares -NSE SME

Accretion Pharmaceuticals IPO Timeline

IPO Open Date
14 May, 2025
IPO Close Date
16 May, 2025
Basis of Allotment
19 May, 2025
Listing Date
21 May, 2025

Issue Price

₹96-101 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Kfin Technologies Limited

Market Lot

1200 Shares (₹121,200/-)

Lead Manager

Jawa Capital Services Private Limited

Issue Size

29,46,000 shares(aggregating up to ₹29.75 Cr)

Retail Portion

Retail : 45%HNI : 45%QIB : 5%

Subscription

7.67 times

IPO Docs

DRHP RHP

Accretion Pharmaceuticals IPO Financial Information

Period EndedAssetsRevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31 Dec 2439.9935.755.2413.585.4113.79
31 Mar 2427.0533.943.885.351.3513.48
31 Mar 2320.5829.530.103.840.008.47
31 Mar 2217.7422.580.083.080.007.61

All values are in ₹ Cr.

Accretion Pharmaceuticals IPO Valuations

EPS PRE IPO

₹4.74/-

EPS POST IPO

₹6.28/-

PE PRE IPO

21.29

PE POST IPO

16.08

ROE

72.47%

ROCE

36.73%

DEBT EQUITY

2.52

RONW

72.47%

PAT MARGIN

11.51

PRICE TO BOOK VALUE

7.55

About Company

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical firm that produces and markets tablets, capsules, and other health care products.

The company provides contract manufacturing services as well. The Company produces and sells Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).The company is also certified by ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005, demonstrating its commitment towards quality and environmental management systems.

The manufacturing facility of the company is situated in Ahmedabad, Sanand, Gujarat.The company has spread its wings globally, representing itself in over 20 countries, with locations in Africa, Southeast Asia, as well as the Middle East.

Product Portfolio and Services:
Tablets and Capsules – Encompassing antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal drugs.
Oral Liquids and Syrups – For respiratory, pediatric, and gastrointestinal treatments.
External Preparations – Such as medicated lotions, gels, ointments, and dusting powders for skin treatment and dermatological therapy.
Ayurvedic and Herbal Products – Emphasizing natural wellness remedies for immunity, digestion, and overall health.

As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.

Read More

Accretion Pharmaceuticals IPO Subscription Details

As onQIB/NIIRetailTotal
Shares Offered / Reserved1,41,600 / 12,22,80012,22,80025,87,200
Day 1 - 14-05-25 06:00 PM0.00 / 0.51 x1.86 x1.12 x
Day 2 - 15-04-25 06:00 PM0.75 / 0.92 x4.01 x2.37 x
Day 3 - 16-05-25 06:00 PM12.14 / 4.28 x10.54 x7.67 x
Total No. of Applications:11,625 (Approx)

Accretion Pharmaceuticals IPO - Issue Objectives

  1. Capital expenditure towards purchase of new equipment/ machineries, etc.
  2. Capital expenditure towards upgradation of existing manufacturing facility
  3. Repayment/prepayme nt of certain borrowings availed by the Company
  4. Funding working capital requirements
  5. General Corporate Purpose
Company Contact Details

Accretion Pharmaceuticals

29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat,India, 382213
Registrar Contact Details

Kfin Technologies Limited

Phone: 04067162222, 04079611000

Email: apl.ipo@kfintech.com

Website: https://kosmic.kfintech.com/ipostatus/